“…In another approach, N -cyclopentylcarbonyl chitosan derivatives, comprising ten 3,6- bis -(arylcarbamate)-2-(cyclopentylformamide) derivatives with different substituents at the phenyl moiety, were synthesized by Fu et al [ 63 ] ( Figure 5 ). Tröger’s base, 2-phenylchroman-4-one, 1-(2-napthyl)-ethanol, methyl phenyl sulfoxide, 1-phenylethanol, mephobarbital, 4-phenyloxazolidin-2-one, 1-(1-phenylethyl)-3-(3-p-tolyl)urea, 1-(2,4-dichlorophenyl)-2-(1 H -imidazol-1-yl)ethanol, 4-methyl- N -(1-phenylethyl)benzamide, benzoin, 1-(1-(4-methoxyphenyl)ethyl)-3-phenylurea, aminoglutethimide, glutethimide, citalopram hydrobromide, efavirenz, N -(1-(4-methoxyphenyl)ethyl)-3,5-dinitobenzamide, omeprazole sodium, 4-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile, and voriconazole were employed as the analytes to evaluate the ES performance of the chitosan-based CSs.…”